FIRST AMONG PHARMACY COMPOUNDERS; ENABLES CONVENIENT, SECURE, VIRTUALLY
REAL-TIME ORDERING OF CLASS II CONTROLLED SUBSTANCES
LAKE FOREST, Ill., Dec. 3 /PRNewswire/ -- PharMEDium Services, LLC, the leading provider of outsourced hospital compounded sterile preparations, announced a first-in-the-industry electronic 222 controlled substance ordering system for its entire line of Schedule II Controlled Substances. The initiative will be launched in beta-site form during the month of December, said David Jonas, PharMEDium Chairman and Chief Executive Officer.
The company's investment in e-222 is consistent with its strong commitment to patient safety, quality, and superior customer service, and aligns with moves by the U.S. Drug Enforcement Administration (DEA) and drug/pharmacy industry leaders to use e-commerce to expedite ordering and reduce errors and rework, Jonas said.
The Drug Enforcement Administration (DEA) Office of Diversion Control (ODC) requires a form 222 for all orders of Schedule II Controlled Substances. Until 2005, these orders were processed only via paper forms, which take about 20 minutes to complete. DEA processes about 5.5 million 222 forms yearly, but the drug industry, notably drug distributors, has rapidly upped electronic orders since the agency's Controlled Substances Ordering System (CSOS) was launched in August 2005. Through July 2007, DEA had processed more than three million electronic CSOS orders since the system went into place, with the typical transaction lasting less than 20 seconds, according to the ODC. DEA estimates that the average electronic 222 form costs $6 to process, as opposed to $39 for a paper form.
"The compounding industry has an important role in enhancing quality
and improving the healthcare system as a whole, an
|SOURCE PharMEDium Services, LLC|
Copyright©2007 PR Newswire.
All rights reserved